Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$3,592,500.00
Apr 1, 2019
For-profit organization
1002150
1002150
To establish a state of the art biotechnology facility to expand its Quality Assessment product lines and to adopt a high-efficiency production process for more antigens.
$3,592,500.00
Apr 1, 2019
For-profit organization
1002150
1002150
To establish a state of the art biotechnology facility to expand its Quality Assessment product lines and to adopt a high-efficiency production process for more antigens.
$2,752,500.00
Apr 1, 2019
For-profit organization
813647
813647
The project is to establish a state of the art biotechnology facility to expand Microbix' Quality Assessment product lines, and to adopt a high-efficiency production process for more antigens.
$249,500.00
Sep 3, 2018
For-profit organization
Rubella BR2s Downstream Process Streamlining
914177
Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by developing and implementing a new, automated bioreactor production platform for production of Rubella virus, its largest and fasted growing product line. Customers around the world, have provided good feedback and have begun transition of their regulated medical devices to use Microbix’ bioreactor product. As a consequence of this customer demand, Microbix will initiate a new project to debottleneck and streamline the purification process: to reduce process steps, increase step automation and to introduce new process control test methodologies.